antigen-coupled blood cell therapy (multiple sclerosis, University of Zurich/Unitectra)

N/A

Report date: 2022/12/27 09:22:54

Base Information

Drug Nameantigen-coupled blood cell therapy (multiple sclerosis, University of Zurich/Unitectra)
Drug Alias Nameantigen-coupled blood cell therapy (multiple sclerosis)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Zurich
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of ZurichUnitectra
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A